PAD

Sunday, November 2, 2025

8:00am - 9:00am PT

Moderator(s)

Joshua Beckman, MD

Chief, Division of Vascular Medicine
UT Southwestern Medical Center
Vascular Medicine
Dallas, Texas, United States

Disclosure(s): Janacare: Stockholder - Privately-held company
Medtronic: Consultant
Merck: Consultant
Novartis: Consultant
Novo Nordisk: Consultant
Regeneron: Consultant
tourmaline: Consultant
Daniella Kadian-Dodov, MD

Associate Professor of Medicine
Icahn School of Medicine at Mount Sinai
Vascular Medicine
New York, New York, United States

Disclosure(s): Abbott Vascular: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Boston Scientific: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Zevra Therapeutics: Advisory Board

Panel(s)

Herbert Aronow, MD, MPH

Medical Director, Heart & Vascular Services
Henry Ford Health
Interventional Cardiology
Detroit, Michigan, United States

Disclosure(s): Amplitude Vascular Systems: Consultant
Medtronic: Advisory Board; Consultant
Philips: Consultant
RapidAI: Consultant
Recor Medical: Advisory Board; Consultant
Silk Road: Consultant
Marc Bonaca, MD, MPH

Professor
University of Colorado
Vascular Medicine
Aurora, Colorado, United States

Disclosure(s): 35Pharma, Inc.; Abbott Labratories; Agios Pharmaceuticals, Inc.; Alexion Pharmaceuticals; Amgen; Anthos Therapeutics, Inc.; Arrowhead Pharmaceuticals; Autonomy Bio, Inc.; Bayer; Bristol-Myers Squibb; Cleerly, Inc.; Cook Regentec: Grants/Research Support Recipient
Eidos Therapeutics, Inc.; EluraBio, Inc.; Esperion Therapeutics, Inc.; Faraday Pharmaceuticals, Inc.; Gasherbrum Bio, Inc.; Insmed; IsomAb Limited; JanOne Biotech Holdings, Inc.; Janssen Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc.: Grants/Research Support Recipient
Lilly USA; Medison Pharma; Merck Sharp & Dohme Corp.; Nectero Medical, Inc.; NewAmsterdam Pharma; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Pfizer; Piper Sandler & Co; PPD Development; Prothena Biosciences; Sanofi; Silence Therapeutics: Grants/Research Support Recipient
Stealth BioTherapeutic, Inc.; Regeneron; Tourmaline Bio, Inc.; VarmX; Verve Therapeutics: Grants/Research Support Recipient
Robert Lookstein, MD, MHCDL

Executive Vice Chairman, Dept of Diagnostic, Molecular, and Interventional Radiology
Icahn School of Medicine at Mount Sinai
Interventional Radiology
New York, New York, United States

Disclosure(s): Abbott Vascular: Consultant
Boston Scientific: Advisory Board
gore medical: Consultant
Imperative Vascular: Advisory Board; Consultant
Innova Vascular: Stockholder - Privately-held company
Medtronic: Advisory Board
Penumbra: Consultant
Siemens: Consultant
Summa: Stockholder - Privately-held company
Thrombolex: Stockholder - Privately-held company
Votis: Stockholder - Privately-held company
Matthew Menard, MD

Associate Professor of Surgery, Harvard Medical School; Co-Director, Endovascular Surgery
Brigham and Women's Hospital
Vascular Surgery
Boston, Massachusetts, United States

Disclosure(s): Anges, Inc: Advisory Board
Regeneron, Inc: Advisory Board
XGen, Inc: Advisory Board

Presentations:

8:00am - 8:07am PT

CLTI: Medicines That Matter
Speaker: Herbert Aronow, MD, MPH – Henry Ford Health
8:07am - 8:14am PT

PAD Guidelines Decoded: Takeaways From AHA/ACC and SVS
Speaker: Daniella Kadian-Dodov, MD – Icahn School of Medicine at Mount Sinai
8:14am - 8:21am PT

The Importance and Impact of Team-Based Care
Speaker: Matthew Menard, MD – Brigham and Women's Hospital
8:21am - 8:34am PT

Panel Discussion
8:34am - 8:41am PT

Implementing Guideline-Directed Medical Therapy in Patients With PAD: Barriers and Solutions
Speaker: Robert Lookstein, MD, MHCDL – Icahn School of Medicine at Mount Sinai
8:41am - 8:48am PT

New Frontiers in PAD: Novel Lipid and Metabolic Agents
Speaker: Marc P. Bonaca, MD, MPH – University of Colorado
8:48am - 9:00am PT

Panel Discussion